10.8 C
Thursday, March 21, 2024

Human Microbiome Market to Reach US$ 2.2 Billion by 2028, TMR Study

Transparency Market Research’s most recent report on the global human microbiome market, covering the historical period of 2017–2019 and forecasting from 2021–2028, highlights that technological advancements, mergers, collaborations, increased venture capital investments, and heightened financing for microbiome projects are expected to fuel market growth during the forecast period.

The global human microbiome market reached US$ 1.3 Bn in 2020 and is projected to grow at a CAGR of 7.1% to reach US$ 2.2 Bn by 2028. Factors such as increasing gastrointestinal disorders, technological advancements, rising investments in human microbiome projects, and awareness about women’s health are driving market growth. Market players are focusing on developing innovative products to gain revenue benefits, but they should address challenges such as clinical trial setbacks, regulatory hurdles, and privacy issues to remain competitive. Accelerating product development is crucial for unlocking revenue opportunities and gaining a competitive edge in the global human microbiome industry.

Get Sample PDF: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3999&utm_source=organic&utm_campaign=MansiR_organic ↗

Metagenomic Sequencing Technology Generates Lucrative Revenue Benefits for Manufacturers

In the global human microbiome market, technologies are categorized into metagenomic sequencing and 16s rRNA sequencing. Metagenomic sequencing is projected to dominate the market, driven by the increasing presence of small-scale product manufacturers worldwide. These manufacturers offer detailed data profiles of individual microbiomes being tested, contributing to the segment’s growth. Moreover, companies in the human microbiome industry are increasing their investments, while partnerships and collaborative efforts among market players to develop technology-driven products are expected to drive the segment’s growth in the forecast period.

Leading players:

AOBiome,Enterome Biosciences SA,Metabiomics Corp. (BioSpherex LLC),Microbiome Therapeutics LLC,Osel, Inc.,Rebiotix, Inc.,Second Genome,Seres Therapeutics,Synthetic Biologics, Inc.,Vedanta Biosciences,4D Pharma,Ferring Pharmaceuticals, and other prominent players

Market Segmentation:

  • Indication
    • Gastrointestinal & Metabolic Disorders
    • Women’s Health
    • Cancer
    • Others
  • Technology
    • 16s rRNA Sequencing
    • Metagenomic Sequencing
  • Therapeutic Area
    • Gastrointestinal Disorders
    • Metabolic Disorders
    • Women’s Health
    • Skin Disorders
    • Others

Key Developments:

  • In April 2021, 4D pharma plc, a leading biotherapeutic company, participated in the Jefferies Microbiome-based Therapeutics Summit to showcase its product portfolio and offerings at the global level
  • In December 2021, 4D pharma plc, a leading developer of the microbiome new drug class also known as Live Biotherapeutic products (LBPs), announced its fecal microbiome analyses from the successful phase 2 trial of Blautix drug. This is widely recommended for the treatment of irritable bowel syndrome coupled with constipation and diarrhea.
  • In June 2021, ENTEROME SA, a clinical-stage biotechnology-driven company, announced the accomplishment and capabilities of its proprietary product GeneMark-HM software, which is highlighted in NAR Genomics and Bioinformatics publications
  • In April 2018, LEO Pharma entered into a partnership with microbiome-therapeutics company Naked Biome, Inc.

Regions Covered:

North America(USA, Canada and Mexico)
Europe(UK, Germany, France and the Rest of Europe)
Asia Pacific(China, Japan, India, and the Rest of the Asia Pacific region)
South America(Brazil, Argentina and the Rest of South America)
Middle East and Africa(GCC and Rest of the Middle East and Africa)

Future Outlook: The future of the human microbiome market looks promising, with ongoing research expected to uncover new therapeutic targets and diagnostic biomarkers. Advancements in technology, such as high-throughput sequencing and bioinformatics, will further propel market growth.

Key Market Study Points:

  • Understanding the microbiome-host interaction in various diseases.
  • Developing novel microbiome-based therapeutics and diagnostics.
  • Assessing the efficacy and safety of microbiome-based interventions.
  • Investigating the role of the microbiome in personalized medicine.

About Transparency Market Research

Transparency Market Research, a global market research company ↗ registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Transparency Market Research Inc.
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com ↗    
Email:  [email protected]
Follow Us: LinkedIn| Twitter| Blog | YouTube

 Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

Michael Maren
Michael Maren
Former marine biologist who likes to spend as much time in the tropics as possible, due to a horrible time I once had in Alaska. Brrrr.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles